Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: Buprenorphine for Individuals in Jail [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating buprenorphine for opioid use disorder in incarcerated individuals is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Friends Research Institute, Inc. | Conditions: Opioid Use Disorder | Phase 3 | Status: RECRUITING